Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis

PHASE2TerminatedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

November 7, 2019

Primary Completion Date

June 15, 2020

Study Completion Date

June 15, 2020

Conditions
Osteoarthritis of the ShoulderAdhesive Capsulitis
Interventions
DRUG

FX006

Single intra-articular injection

DRUG

Normal Saline

Single intra-articular injection

Trial Locations (27)

16602

University Orthopedics Center, Altoona

16635

Altoona Center for Clinical Research, Duncansville

20902

Arthritis and Rheumatism Associates PC, Wheaton

22704

M3 Emerging Medical Research, Durham

24541

Spectrum Medical, Inc., Danville

30265

Better Health Clinical Research, Inc., Newnan

32822

Jewitt Orthopedic Center, Orlando

33030

Universal Axon Clinical Research, Homestead

33133

Infinite Clinical Research, Miami

33319

Precision Clinical Research, Lauderdale Lakes

34209

Coastal Orthopaedics and Sports Medicine, Bradenton

34232

Gulfcoast Research Institute, Sarasota

34711

South Lake Pain Institute, Clermont

35205

Central Research Associates, Birmingham

35235

Alabama Clinical Therapeutics, LLC, Birmingham

35243

Affinity Orthopedic Specialists, Birmingham

36608

Coastal Clinical Research, Inc., Mobile

67205

Professional Research Network of Kansas, LLC, Wichita

76021

Texas Orthopedic Specialists, Bedford

77058

Centex Studies, Inc., Houston

80209

Mountain View Clinical Research Center, Denver

85053

Arizona Research Center, Phoenix

85712

Tucson Orthopaedic Institute, Tucson

91924

BioSolutions Clinical Research Center, La Mesa

92020

TriWest Research Associates, El Cajon

92924

CORE Orthopedic Medical Center, Encinitas

08009

Hassman Research Institute, Berlin

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medpace, Inc.

INDUSTRY

lead

Pacira Pharmaceuticals, Inc

INDUSTRY